Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Early Blast Clearance Evaluation after Induction Chemotherapy for Acute Myeloid Leukemia By Multiparameter Flow Cytometry and WT1-RNA Quantification: A Single Center Experience

Carlo Messina, MD, Matteo G Carrabba, MD, Elisa Sala, MD, Michela Tassara, MD, Raffaella Milani, MD, Paola Ronchi, MD, Cristina Tresoldi, MSc, Francesca Pavesi, MD, Jacopo Peccatori, MD, Consuelo Corti, MD, Claudio Bordignon, MD, Fabio Ciceri, MD, Massimo Bernardi, MD

Blood (2014) 124 (21): 5333.

https://doi.org/10.1182/blood.V124.21.5333.5333

Published: 2014

Journal Articles

Allogeneic Stem Cell Transplantation in Patients with Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndromes: Effect of Patient Characteristics and Treatment History.

Francesco Spina, MD, Emilio Paolo Alessandrino, MD, Lucia Farina, MD, PhD, Raffaella Milani, MD, Francesca Bonifazi, MD, Massimo Bernardi, MD, Roberto Lucksh, MD, Franca Fagioli, MD, Paolo Corradini, MD

Blood (2010) 116 (21): 4577.

https://doi.org/10.1182/blood.V116.21.4577.4577

Published: 2010

Journal Articles

Outcome of Hodgkin's Lymphoma Patients After Reduced-Intensity Allogeneic Stem Cell Transplantation: Complete Remission Status Has the Most Relevant Clinical Impact along with Extranodal Disease and C-Reactive Protein Before Transplant

Lucia Farina, Francesco Spina, Anna Dodero, Simonetta Viviani, Vittorio Montefusco, Raffaella Milani, MD, Serena Dalto, Jacopo Mariotti, Carmelo Carlo-Stella, Paolo Corradini

Blood (2010) 116 (21): 3542.

https://doi.org/10.1182/blood.V116.21.3542.3542

Published: 2010

Journal Articles

Prognostic Value of Positron Emission Tomography (PET) Scan in Patients with Relapsed Hodgkin Lymphoma or Aggressive Non-Hodgkin Lymphoma Receiving Salvage Chemotherapy Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation.

Anna Dodero, MD, Roberto Crocchiolo, MD, Francesca Patriarca, MD, Fabio Ciceri, MD, Nicolo’ Frungillo, MD, Roberto Fanin, MD, Rosalba Miceli, MD, Andrea Assanelli, MD, Raffaella Milani, MD, Flavio Crippa, MD, Paolo Corradini, MD

Blood (2007) 110 (11): 3039.

https://doi.org/10.1182/blood.V110.11.3039.3039

Published: 2007

Journal Articles

Improved Immune Reconstitution Following Pre-Emptive CD8-Depleted Donor Lymphocyte Infusions (DLIs) after Haploidentical Stem Cell Transplantation (SCT) Using a Reduced-Intensity Conditioning (RIC) Regimen.

Paolo Corradini, MD, Anna Raganato, MD, Matteo Carrabba, MD, Lorenza Gandola, MD, Claudia Lombardo, MD, Cristiana Carniti, MD, Lucia Farina, MD, Raffaella Milani, MD, Anna Dodero, MD

Blood (2005) 106 (11): 2908.

https://doi.org/10.1182/blood.V106.11.2908.2908

Published: 2005

Journal Articles

Placental Growth Factor (PlGF) Synergizes with Granulocyte Colony-Stimulating Factor (G-CSF) for the Mobilization of Primitive and Committed Peripheral Blood Progenitor Cells (PBPCs) in Nonhuman Primates.

Carmelo Carlo-Stella, MD, Massimo Di Nicola, MD, Paolo Longoni, Raffaella Milani, MD, Marco Milanesi, Michele Magni, MD, Loredana Cleris, Franca Formelli, PhD, Virgilio Pace, DVM, Francesco Colotta, MD, Alessandro M. Gianni, MD

Blood (2004) 104 (11): 4994.

https://doi.org/10.1182/blood.V104.11.4994.4994

Published: 2004

Journal Articles

Primary Plasma Cells Expressing CD52 Are Efficiently Targeted In Vivo by Alemtuzumab.

Carmelo Carlo-Stella, MD, Massimo Di Nicola, MD, Paolo Longoni, Loredana Cleris, Marco Milanesi, Cristiana Lavazza, PhD, Raffaella Milani, MD, Matteo Carrabba, MD, Franca Formelli, PhD, Alessandro M. Gianni, MD, Paolo Corradini, MD

Blood (2004) 104 (11): 3460.

https://doi.org/10.1182/blood.V104.11.3460.3460

Published: 2004

Journal Articles

Reduced-Intensity Conditioning (RIC) Followed by Allogeneic Transplantation in Relapsed Lymphomas: Evidence for Graft-Versus-Lymphoma Effect in Low and High Grade Histologies, but Not in Hodgkin Disease.

Paolo Corradini, MD, Anna Dodero, MD, Marco Bregni, MD, Attilio Olivieri, MD, Lucia Farina, MD, Elena Rizzo, MD, Raffaella Milani, MD, Rosanna Scime, MD, Alessandro Rambaldi, MD, Francesca Bonifazi, MD, Francesca Patriarca, MD, Anna Locasciulli, MD, Andrea Bacigalupo, MD, Alessandro Massimo Gianni, MD, Corrado Tarella, MD

Blood (2004) 104 (11): 808.

https://doi.org/10.1182/blood.V104.11.808.808

Published: 2004

NARROW

Early Blast Clearance Evaluation after Induction Chemotherapy for Acute Myeloid Leukemia By Multiparameter Flow Cytometry and WT1-RNA Quantification: A Single Center Experience

Allogeneic Stem Cell Transplantation in Patients with Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndromes: Effect of Patient Characteristics and Treatment History.

Outcome of Hodgkin's Lymphoma Patients After Reduced-Intensity Allogeneic Stem Cell Transplantation: Complete Remission Status Has the Most Relevant Clinical Impact along with Extranodal Disease and C-Reactive Protein Before Transplant

Prognostic Value of Positron Emission Tomography (PET) Scan in Patients with Relapsed Hodgkin Lymphoma or Aggressive Non-Hodgkin Lymphoma Receiving Salvage Chemotherapy Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation.

Improved Immune Reconstitution Following Pre-Emptive CD8-Depleted Donor Lymphocyte Infusions (DLIs) after Haploidentical Stem Cell Transplantation (SCT) Using a Reduced-Intensity Conditioning (RIC) Regimen.

Placental Growth Factor (PlGF) Synergizes with Granulocyte Colony-Stimulating Factor (G-CSF) for the Mobilization of Primitive and Committed Peripheral Blood Progenitor Cells (PBPCs) in Nonhuman Primates.

Primary Plasma Cells Expressing CD52 Are Efficiently Targeted In Vivo by Alemtuzumab.

Reduced-Intensity Conditioning (RIC) Followed by Allogeneic Transplantation in Relapsed Lymphomas: Evidence for Graft-Versus-Lymphoma Effect in Low and High Grade Histologies, but Not in Hodgkin Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only